EVOKE PHARMA, INC. Total Liabilities and Equity
EVOKE PHARMA, INC. had Total Liabilities and Equity of $15.65 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2025-11-13
- 2025-09-30: Liabilities and Equity $15.65M.
- 2025-06-30: Liabilities and Equity $16.06M.
- 2025-03-31: Liabilities and Equity $16.38M.
- 2024-12-31: Liabilities and Equity $17.52M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2025-09-30 | $15.65M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $16.06M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $16.38M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $17.52M 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $14.15M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $12.14M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $12.45M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.07M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $7.85M 10-K/A · filed 2024-05-14 | |
| 2023-06-30 | $8.98M 10-K/A · filed 2024-05-14 | |
| 2023-03-31 | $10.04M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.85M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $13.41M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $14.40M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $9.03M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $10.57M 10-K · filed 2023-03-21 | |
| 2021-09-30 | $11.65M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $17.56M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $19.30M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $9.43M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $6.75M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $8.27M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.64M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $6.40M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $7.33M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $7.63M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.36M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $5.66M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $7.02M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $6.63M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $5.58M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $7.94M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $10.76M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $13.16M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $14.84M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $9.29M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $10.81M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.64M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.87M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $9.53M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $11.68M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $10.61M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $12.62M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $15.23M 10-K · filed 2016-03-10 | $15.30M 10-K · filed 2015-03-04 |
| 2014-09-30 | $13.39M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $17.02M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $22.57M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $24.99M 10-K · filed 2015-03-04 | |
| 2013-09-30 | $23.74M 10-Q · filed 2013-11-13 | |
| 2012-12-31 | $116.01K 10-K · filed 2014-03-25 |